Francesco Pallone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Francesco Pallone has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
- Emma Calabrese
Gastroenterology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
25 shared publications - Livia Biancone
From the Cattedra di Gastroenterologia e
23 shared publications Francesca Zorzi
22 shared publications- Sara Onali
Department of Biomedicine and Prevention, University of Rome “Tor Vergata”, 00133 Rome, Italy
19 shared publications Carmelina Petruzziello
16 shared publicationsGiovanna Condino
14 shared publications
Latest Publications
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S433-S434
Sa2028 Inter-Observer Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S433-S434
Sa2028 Inter-Observer Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease
- Open Access
- 2 April 2015
- Published by Springer Nature in BMC Medical Genetics
- Vol. 16 (1) , 1-10
Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: a novel recognizable microdeletion syndrome?
Copy number variations (CNVs) can contribute to genetic variation among individuals and/or have a significant influence in causing diseases. Many studies consider new CNVs’ effects on protein family evolution giving rise to gene duplicates or losses. “Unsuccessful” duplicates that remain in the genome as pseudogenes often exhibit functional roles. So, changes in gene and pseudogene number may contribute to development or act as susceptibility alleles of diseases. We report a de novo heterozygous 271 Kb microdeletion at 8q21.2 region which includes the family of REXO1L genes and pseudogenes in a young man affected by global development delay, progeroid signs, and gastrointestinal anomalies. Molecular and cellular analysis showed that the REXO1L1 gene hemizygosity in a patient’s fibroblasts induces genetic instability and increased apoptosis after treatment with different DNA damage-induced agents. The present results support the hypothesis that low copy gene number within REXO1L1 cluster could play a significant role in this complex clinical and cellular phenotype.
- 2 April 2015
- Published by Springer Nature in BMC Medical Genetics
- Vol. 16 (1) , 1-10
Open AccessDeletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: a novel recognizable microdeletion syndrome?
Copy number variations (CNVs) can contribute to genetic variation among individuals and/or have a significant influence in causing diseases. Many studies consider new CNVs’ effects on protein family evolution giving rise to gene duplicates or losses. “Unsuccessful” duplicates that remain in the genome as pseudogenes often exhibit functional roles. So, changes in gene and pseudogene number may contribute to development or act as susceptibility alleles of diseases. We report a de novo heterozygous 271 Kb microdeletion at 8q21.2 region which includes the family of REXO1L genes and pseudogenes in a young man affected by global development delay, progeroid signs, and gastrointestinal anomalies. Molecular and cellular analysis showed that the REXO1L1 gene hemizygosity in a patient’s fibroblasts induces genetic instability and increased apoptosis after treatment with different DNA damage-induced agents. The present results support the hypothesis that low copy gene number within REXO1L1 cluster could play a significant role in this complex clinical and cellular phenotype.
- Open Access
- 27 November 2013
- Published by Springer Nature in BMC Gastroenterology
- Vol. 13 (1) , 162
Pyoderma gangrenosum in refractory celiac disease: a case report
Background: Pyoderma gangrenosum is an inflammatory neutrophilic dermatosis characterized by painful cutaneous ulcerations and often associated with systemic inflammatory and neoplastic diseases. Here we report the first case of pyoderma gangrenosum in a patient with refractory celiac disease. Case presentation: A 52-year-old woman with a previously diagnosed refractory celiac disease resistant to steroids and immunosuppressive drugs presented to our hospital for a rapidly growing, painful inflammatory skin lesion of the left leg. Physical examination revealed a painful lesion with focal ulceration, necrosis and pus discharge with active inflammatory borders at the external part of the left leg. Histological evaluation of a skin biopsy and analysis of inflammatory cytokines and matrix-degrading proteases in lesional skin samples confirmed the clinical suspicion of pyoderma gangrenosum. Treatment with oral prednisone was rapidly followed by a complete healing of the skin lesion but no improvement of symptoms/signs of malabsorption. Conclusion: Treatment of the patient with systemic steroids healed the skin lesion without improving the underlying refractory celiac disease. This observation raises the possibility that refractory celiac disease and pyoderma gangrenosum may be immunologically different.
- 27 November 2013
- Published by Springer Nature in BMC Gastroenterology
- Vol. 13 (1) , 162
Open AccessPyoderma gangrenosum in refractory celiac disease: a case report
Background: Pyoderma gangrenosum is an inflammatory neutrophilic dermatosis characterized by painful cutaneous ulcerations and often associated with systemic inflammatory and neoplastic diseases. Here we report the first case of pyoderma gangrenosum in a patient with refractory celiac disease. Case presentation: A 52-year-old woman with a previously diagnosed refractory celiac disease resistant to steroids and immunosuppressive drugs presented to our hospital for a rapidly growing, painful inflammatory skin lesion of the left leg. Physical examination revealed a painful lesion with focal ulceration, necrosis and pus discharge with active inflammatory borders at the external part of the left leg. Histological evaluation of a skin biopsy and analysis of inflammatory cytokines and matrix-degrading proteases in lesional skin samples confirmed the clinical suspicion of pyoderma gangrenosum. Treatment with oral prednisone was rapidly followed by a complete healing of the skin lesion but no improvement of symptoms/signs of malabsorption. Conclusion: Treatment of the patient with systemic steroids healed the skin lesion without improving the underlying refractory celiac disease. This observation raises the possibility that refractory celiac disease and pyoderma gangrenosum may be immunologically different.
- 1 July 2013
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 7 (6) , 441-450
“In vitro” azathioprine-induced changes in peripheral T cell apoptosis and IFN-γ production associate with drug response in patients with Crohn's Disease
Background and aim: The use of the highly effective thiopurines as early therapeutic option in Crohn's Disease (CD) may be discouraged by the long time interval required to obtain clinical efficacy as also by their potential side effects. The development of non-invasive markers of responsiveness to thiopurines represents a major attempt in the clinical management of CD patients. Azathioprine is able to induce apoptosis of T cells. We studied the effect of thiopurines on "in vitro" T cell apoptosis, IFN-gamma and IL-10 production in a group of CD patients with known response to a previous treatment with AZA. Methods: Heparinized blood samples were drawn from 25 CD patients showing or not a previous responsiveness to a conventional azathioprine treatment (n=17 and n=8, respectively). CD4+ T cells were stimulated "in vitro" with aCD3/28 mAbs in the presence or absence of azathioprine, 6-mercaptopurine or 6-thioguanine. Apoptosis was assessed using Annexin V staining, and IFN-gamma and IL-10 production in cell culture supernatants was evaluated by ELISA. Results: Apoptosis stimulation index (% of apoptotic cells in the presence of thiopurine/% of apoptotic cells in the absence of thiopurine) and IFN-gamma stimulation index (IFN-gamma production in the presence of thiopurine/IFN-gamma production in the absence of thiopurine) were, respectively, significantly lower and higher in non-responder when compared to responder patients. No variation was observed in IL-10 production. Conclusions: Evaluation of apoptosis and IFN-gamma stimulation index of peripheral CD4+ T cell may be useful for a proper selection of CD patients candidate to thiopurine treatment. (C) 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
- 1 July 2013
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 7 (6) , 441-450
“In vitro” azathioprine-induced changes in peripheral T cell apoptosis and IFN-γ production associate with drug response in patients with Crohn's Disease
Background and aim: The use of the highly effective thiopurines as early therapeutic option in Crohn's Disease (CD) may be discouraged by the long time interval required to obtain clinical efficacy as also by their potential side effects. The development of non-invasive markers of responsiveness to thiopurines represents a major attempt in the clinical management of CD patients. Azathioprine is able to induce apoptosis of T cells. We studied the effect of thiopurines on "in vitro" T cell apoptosis, IFN-gamma and IL-10 production in a group of CD patients with known response to a previous treatment with AZA. Methods: Heparinized blood samples were drawn from 25 CD patients showing or not a previous responsiveness to a conventional azathioprine treatment (n=17 and n=8, respectively). CD4+ T cells were stimulated "in vitro" with aCD3/28 mAbs in the presence or absence of azathioprine, 6-mercaptopurine or 6-thioguanine. Apoptosis was assessed using Annexin V staining, and IFN-gamma and IL-10 production in cell culture supernatants was evaluated by ELISA. Results: Apoptosis stimulation index (% of apoptotic cells in the presence of thiopurine/% of apoptotic cells in the absence of thiopurine) and IFN-gamma stimulation index (IFN-gamma production in the presence of thiopurine/IFN-gamma production in the absence of thiopurine) were, respectively, significantly lower and higher in non-responder when compared to responder patients. No variation was observed in IL-10 production. Conclusions: Evaluation of apoptosis and IFN-gamma stimulation index of peripheral CD4+ T cell may be useful for a proper selection of CD patients candidate to thiopurine treatment. (C) 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Su1199 Small Bowel Capsule Endoscopy for Assessing Early Postoperative Recurrence of Crohn's Disease: A Prospective Longitudinal Study
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Su1199 Small Bowel Capsule Endoscopy for Assessing Early Postoperative Recurrence of Crohn's Disease: A Prospective Longitudinal Study
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Su1117 Contrast Enhanced Ultrasound As a Valuable Tool in Complicated Crohn's Disease Patients
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Su1117 Contrast Enhanced Ultrasound As a Valuable Tool in Complicated Crohn's Disease Patients
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
493 Bowel Damage After Biological Therapy Assessed by Sonographic Lesion Index for Crohn's Disease
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
493 Bowel Damage After Biological Therapy Assessed by Sonographic Lesion Index for Crohn's Disease
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Mo1244 Psoriasis Phenotype in Inflammatory Bowel Disease
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Mo1244 Psoriasis Phenotype in Inflammatory Bowel Disease
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Su1120 Impact of Small Intestine Contrast Ultrasonography in the Management of Crohn's Disease Patients
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Su1120 Impact of Small Intestine Contrast Ultrasonography in the Management of Crohn's Disease Patients
- 1 August 2012
- Published by Bentham Science Publishers Ltd. in Current Drug Targets
- Vol. 13 (10) , 1224-1233
Ultrasound in Crohn’s Disease
Over the past few years, the technical evolution of ultrasound equipment, the use of oral and intravenous contrast agents, and an increase in the expertise of sonographers has enhanced the role of ultrasonography that plays in the assessment of the gastrointestinal tract. In chronic inflammatory conditions, primarily CD, this technology can be used not only for diagnostic purposes, but it has also been suggested that it could play a role in the management of the disease.
- 1 August 2012
- Published by Bentham Science Publishers Ltd. in Current Drug Targets
- Vol. 13 (10) , 1224-1233
Ultrasound in Crohn’s Disease
Over the past few years, the technical evolution of ultrasound equipment, the use of oral and intravenous contrast agents, and an increase in the expertise of sonographers has enhanced the role of ultrasonography that plays in the assessment of the gastrointestinal tract. In chronic inflammatory conditions, primarily CD, this technology can be used not only for diagnostic purposes, but it has also been suggested that it could play a role in the management of the disease.